Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
4.000
+0.290 (7.82%)
At close: Nov 4, 2024, 4:00 PM
3.913
-0.087 (-2.16%)
Pre-market: Nov 5, 2024, 9:23 AM EST

Cabaletta Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-89.98-67.68-52.98-46.29-33.34-16.94
Upgrade
Depreciation & Amortization
1.511.431.180.730.350.1
Upgrade
Loss (Gain) From Sale of Investments
-2.21-1.22-0.220.060.12-
Upgrade
Stock-Based Compensation
14.8611.346.95.84.392.3
Upgrade
Other Operating Activities
4.942.483.04---
Upgrade
Change in Accounts Payable
2.141.68-0.030.980.560.25
Upgrade
Change in Other Net Operating Assets
-5.1-1.57-4.274.611.15-1.75
Upgrade
Operating Cash Flow
-73.83-53.55-46.38-34.11-26.77-16.05
Upgrade
Capital Expenditures
-1.83-0.69-2.45-1.17-0.64-0.69
Upgrade
Investment in Securities
25.82-21.76-24.767.17-7.35-
Upgrade
Investing Cash Flow
23.99-22.45-27.226-7.98-0.69
Upgrade
Issuance of Common Stock
100.38187.6332.9848.90.1771.22
Upgrade
Other Financing Activities
-----0.19-1.29
Upgrade
Financing Cash Flow
100.38187.6332.9848.9-0.02119.93
Upgrade
Net Cash Flow
50.54111.63-40.6220.79-34.78103.19
Upgrade
Free Cash Flow
-75.66-54.24-48.83-35.28-27.41-16.74
Upgrade
Free Cash Flow Per Share
-1.61-1.32-1.66-1.37-1.18-3.06
Upgrade
Levered Free Cash Flow
-45.62-30.41-29.25-17.82-15.53-11.13
Upgrade
Unlevered Free Cash Flow
-45.62-30.41-29.25-17.82-15.53-11.13
Upgrade
Change in Net Working Capital
-2.41-4.171.04-5.75-1.511.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.